A Growing Number of Biopharmas Leverage Veeva Compass Patient to Improve Commercialization
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| VEEVA SYSTEMS, Inc. (NYSE: VEEV) | Delayed: 310.13 +6.92 (2.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $303.21 | 52 Week High | $42.58 | |||
| Open | $306.62 | 52 Week Low | $19.97 | |||
| Day High | $310.19 | P/E | 10,337.67 | |||
| Day Low | $302.42 | EPS | $0.03 | |||
| Volume | 785,282 | |||||
